Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Vij

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Carfilzomib in multiple myelomaRavi Vij
Leukemia & Lymphoma|April 7, 2009
Clofarabine: a size that fits all, may not fit allRavi Vij
Oncology (Williston Park, N.Y.)|September 5, 2014
Treatment-related adverse events in patients with relapsed/refractory multiple myelomaRavi Vij
Nature Reviews. Clinical Oncology|October 9, 2013
Haematological cancer: a step before the next leap?Ravi Vij
Leukemia & Lymphoma|January 7, 2012
Evolution of definitions of response, progression-free survival and event-free survival in front-line studies of chronic myeloid leukemiaGeorge Ansstas, Ravi Vij
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Clonal Evolution in Multiple MyelomaBita Fakhri, Ravi Vij
Clinical Lymphoma & Myeloma|September 1, 2009
Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literatureMike G Martin, Ravi Vij
JCO Oncology Practice|June 10, 2021
Evolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future DirectionsScott R Goldsmith, Ravi Vij
Pharmacogenomics and Personalized Medicine|February 19, 2015
Targeted treatments for multiple myeloma: specific role of carfilzomibDhivya Sugumar, Jesse Keller, Ravi Vij
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2015
New Approaches to Molecular Imaging of Multiple MyelomaRavi Vij, Kathryn J Fowler, Monica Shokeen
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Carfilzomib in multiple myelomaRavi Vij
Leukemia & Lymphoma|April 7, 2009
Clofarabine: a size that fits all, may not fit allRavi Vij
Oncology (Williston Park, N.Y.)|September 5, 2014
Treatment-related adverse events in patients with relapsed/refractory multiple myelomaRavi Vij
Nature Reviews. Clinical Oncology|October 9, 2013
Haematological cancer: a step before the next leap?Ravi Vij
Leukemia & Lymphoma|January 7, 2012
Evolution of definitions of response, progression-free survival and event-free survival in front-line studies of chronic myeloid leukemiaGeorge Ansstas, Ravi Vij
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Clonal Evolution in Multiple MyelomaBita Fakhri, Ravi Vij
Clinical Lymphoma & Myeloma|September 1, 2009
Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literatureMike G Martin, Ravi Vij
JCO Oncology Practice|June 10, 2021
Evolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future DirectionsScott R Goldsmith, Ravi Vij
Pharmacogenomics and Personalized Medicine|February 19, 2015
Targeted treatments for multiple myeloma: specific role of carfilzomibDhivya Sugumar, Jesse Keller, Ravi Vij
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2015
New Approaches to Molecular Imaging of Multiple MyelomaRavi Vij, Kathryn J Fowler, Monica Shokeen
Pageof 29